RA Capital Management - BLACK DIAMOND THERAPEUTICS I ownership

BLACK DIAMOND THERAPEUTICS I's ticker is BDTX and the CUSIP is 09203E105. A total of 112 filers reported holding BLACK DIAMOND THERAPEUTICS I in Q1 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
RA Capital Management ownership history of BLACK DIAMOND THERAPEUTICS I
ValueSharesWeighting
Q3 2023$10,118,914
-43.2%
3,525,7540.0%0.20%
-40.8%
Q2 2023$17,805,058
+263.7%
3,525,754
+36.1%
0.34%
+202.7%
Q1 2023$4,894,919
+5.0%
2,589,9040.0%0.11%
+16.8%
Q4 2022$4,661,827
+6.5%
2,589,9040.0%0.10%
+2.2%
Q3 2022$4,377,000
-31.3%
2,589,9040.0%0.09%
-45.3%
Q2 2022$6,371,000
-11.2%
2,589,9040.0%0.17%
+8.3%
Q1 2022$7,174,000
-48.0%
2,589,9040.0%0.16%
-35.4%
Q4 2021$13,804,000
-37.0%
2,589,9040.0%0.24%
-20.1%
Q3 2021$21,911,000
-30.6%
2,589,9040.0%0.30%
-40.0%
Q2 2021$31,571,000
-49.8%
2,589,9040.0%0.51%
-46.5%
Q1 2021$62,831,000
-24.3%
2,589,9040.0%0.95%
-18.4%
Q4 2020$83,006,000
+6.0%
2,589,9040.0%1.16%
-19.0%
Q3 2020$78,293,000
-28.3%
2,589,9040.0%1.43%
-32.7%
Q2 2020$109,190,000
+69.0%
2,589,9040.0%2.13%
+4.3%
Q1 2020$64,618,0002,589,9042.04%
Other shareholders
BLACK DIAMOND THERAPEUTICS I shareholders Q1 2021
NameSharesValueWeighting ↓
NEA Management Company, LLC 3,449,845$110,568,0002.92%
Boxer Capital, LLC 2,014,858$64,576,0002.08%
RA Capital Management 2,589,904$83,006,0001.16%
Artal Group S.A. 1,646,517$52,771,0001.13%
Burrage Capital Management LLC 34,891$1,118,0000.85%
Bellevue Group AG 1,403,000$44,967,0000.52%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 802,511$25,720,0000.51%
Ikarian Capital, LLC 293,941$9,421,0000.42%
Avoro Capital Advisors LLC 640,000$20,512,0000.35%
Logos Global Management LP 123,465$3,957,0000.34%
View complete list of BLACK DIAMOND THERAPEUTICS I shareholders